Abstract | BACKGROUND: METHODS: Seventy patients with impaired left ventricular function [left ventricular ejection fraction (LVEF) < 35%] undergoing on-pump CABG were enrolled. Patients were randomized to receive either an intraoperative bolus of milrinone (50 microg/kg) or saline as placebo followed by a 24-hour infusion of each agent (0.5 microg/kg/min). Hemodynamic parameters and transthoracic echocardiographic measurement of systolic and diastolic functions were the variables evaluated. RESULTS: CONCLUSIONS: We suggest that perioperative administration of milrinone in patients undergoing on-pump CABG, especially those with low LVEF, is beneficial.
|
Authors | Mohammad Jebeli, Mohammad Ghazinoor, Mohammad Hussein Mandegar, Mohammad R Rasouli, Payam Eghtesadi-Araghi, Hamidreza Goodarzynejad, Robabeh Mohammadzadeh, Ali Darehzereshki, Saied Dianat |
Journal | Cardiology journal
(Cardiol J)
Vol. 17
Issue 1
Pg. 73-8
( 2010)
ISSN: 1898-018X [Electronic] Poland |
PMID | 20104460
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Cardiotonic Agents
- Creatine Kinase
- Creatine Kinase, MB Form
- Milrinone
|
Topics |
- Aged
- Cardiotonic Agents
(administration & dosage)
- Coronary Artery Bypass
- Creatine Kinase
(blood)
- Creatine Kinase, MB Form
(blood)
- Drug Administration Schedule
- Echocardiography
- Female
- Humans
- Incidence
- Infusions, Intravenous
- Injections, Intravenous
- Male
- Middle Aged
- Milrinone
(administration & dosage)
- Myocardial Infarction
(epidemiology, etiology)
- Myocardial Ischemia
(epidemiology, etiology)
- Perioperative Care
- Stroke Volume
- Time Factors
- Treatment Outcome
- Ventricular Dysfunction, Left
(diagnostic imaging, drug therapy, physiopathology, surgery)
|